Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 20: 5-14, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zettner, A.
Right arrow Articles by Duly, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zettner, A.
Right arrow Articles by Duly, P. E.

Clinical Chemistry, Vol 20, 5-14, Copyright © 1974 by the American Association for Clinical Chemistry

Principles of Competitive Binding Assays (Saturation Analyses). II. Sequential Saturation

Alfred Zettner 1 and Peggy E. Duly 1

1 Division of Clinical Pathology, Department of Pathology, School of Medicine, University of California, San Diego.

The principles of sequential saturation as a form of competitive binding assays are discussed in detail and differentiated from those of equilibrium techniques. The rationale of its applicability in practice and its potential to increase sensitivity under certain assay conditions are demonstrated with three binding systems involving digoxin, insulin, and folates. The advantages and disadvantages of the sequential saturation technique are outlined.


Key Words: radioimmunoassay • equilibrium assay technique compared with sequential saturation technique • dose-response curves • digoxin-, insulin-, and folate-binding systems • advantages and disadvantages ot the sequential saturation technique

Submitted on October 17, 1973
Accepted on November 6, 1973







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.